Acute myeloid leukaemia and Haematocrit abnormal

Summary:

Haematocrit abnormal is found among people with Acute myeloid leukaemia, especially for people who are male, 60+ old.

The study analyzes which people have Haematocrit abnormal with Acute myeloid leukaemia. It is created by eHealthMe based on reports of 17 people who have Acute myeloid leukaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Acute myeloid leukaemia?

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts) is found to be associated with 721 drugs and 1,223 conditions by eHealthMe. Check the latest studies of Acute myeloid leukaemia.

What is Haematocrit abnormal?

Haematocrit abnormal is found to be associated with 280 drugs and 595 conditions by eHealthMe. Check the latest studies of Haematocrit abnormal.

On Jul, 20, 2026

17 people who have Acute Myeloid Leukaemia and Haematocrit Abnormal are studied.

Would you have Haematocrit abnormal when you have Acute myeloid leukaemia?

Gender of people who have Acute Myeloid Leukaemia and experienced Haematocrit Abnormal *:

female: 41.18 %
male: 58.82 %

Age of people who have Acute Myeloid Leukaemia and experienced Haematocrit Abnormal *:

Common drugs taken by these people *:

Common symptoms for these people *:

Platelet Count Abnormal: 10 people, 58.82%
Thrombocytopenia (decrease of platelets in blood): 7 people, 41.18%
Haemoglobin Abnormal: 5 people, 29.41%
Fever: 5 people, 29.41%
Blood Creatinine Increased: 3 people, 17.65%
Dyspnea (difficult or laboured breathing): 3 people, 17.65%
Diarrhea: 3 people, 17.65%
Blood Urea Abnormal: 3 people, 17.65%
Cough: 3 people, 17.65%
Cardiac Failure Congestive: 3 people, 17.65%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Haematocrit abnormal?

- Check whether Haematocrit abnormal is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Haematocrit abnormal and Acute myeloid leukaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.